Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 15

1.

The predictive value of p53 and p33(ING1b) in patients with Dukes'C colorectal cancer.

Ahmed IA, Kelly SB, Anderson JJ, Angus B, Challen C, Lunec J.

Colorectal Dis. 2008 May;10(4):344-51. Epub 2007 Oct 19.

PMID:
17949449
2.

The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.

Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N; TP53-CRC Collaborative Study Group.

J Clin Oncol. 2005 Oct 20;23(30):7518-28. Epub 2005 Sep 19. Review.

PMID:
16172461
3.

TP53 mutation in colorectal cancer.

Iacopetta B.

Hum Mutat. 2003 Mar;21(3):271-6. Review.

PMID:
12619112
4.

Adjuvant chemotherapy for colorectal cancer.

Rayter Z, Leicester RJ, Mansi JL.

Ann R Coll Surg Engl. 1995 Mar;77(2):81-4. Review.

5.

Prognostic biomarkers in resected colorectal cancer: implications for adjuvant chemotherapy.

Graziano F, Catalano V, Baldelli AM, Cascinu S.

Expert Rev Anticancer Ther. 2001 Aug;1(2):247-57. Review.

PMID:
12113030
6.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
8.

[Molecular markers as basis for chemotherapy?].

Brabender J, Lenz HJ, Danenberg PV.

Chirurg. 2000 Dec;71(12):1433-9. Review. German.

PMID:
11195061
9.

Drug resistance, predictive markers and pharmacogenomics in colorectal cancer.

Longley DB, Allen WL, Johnston PG.

Biochim Biophys Acta. 2006 Dec;1766(2):184-96. Epub 2006 Aug 9. Review.

PMID:
16973289
10.

Critical evaluation of p53 as a prognostic marker in ovarian cancer.

Hall J, Paul J, Brown R.

Expert Rev Mol Med. 2004 May 17;6(12):1-20. Review.

PMID:
15147608
11.

Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy.

Smith FM, Reynolds JV, Miller N, Stephens RB, Kennedy MJ.

Eur J Surg Oncol. 2006 Feb;32(1):55-64. Epub 2005 Dec 1. Review.

PMID:
16324817
12.

Genetic testing and surgeon decision.

Guanti G.

Acta Chir Iugosl. 2004;51(2):57-60. Review.

PMID:
15771290
13.

Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer.

Suppiah A, Greenman J.

World J Gastroenterol. 2013 Aug 7;19(29):4651-70. doi: 10.3748/wjg.v19.i29.4651. Review.

14.

Assessing p53 in clinical contexts: unlearned lessons and new perspectives.

Hall PA, McCluggage WG.

J Pathol. 2006 Jan;208(1):1-6. Review.

PMID:
16331594
15.

P53 abnormalities and outcomes in colorectal cancer: a systematic review.

Smith FM, Stephens RB, Kennedy MJ, Reynolds JV.

Br J Cancer. 2005 May 9;92(9):1813. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk